Plain-English translation of NCT05754593 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking at whether multiple sclerosis affects a woman's ovarian reserve—the quality and quantity of eggs available for fertility. Researchers will measure two key markers: a hormone called Anti-Mullerian Hormone (AMH) through a blood test, and a count of developing egg follicles through ultrasound imaging. By comparing women with MS to healthy women of the same age, the study aims to understand if MS poses a fertility risk that women should plan for.
Multiple sclerosis typically strikes women in their reproductive years, but very few studies have looked at whether the disease or its inflammatory nature affects fertility. If MS does impact egg supply, women diagnosed with the condition could benefit from early conversations about fertility preservation options—like freezing eggs—before they're needed.
You likely qualify if…
You likely don't qualify if…
You would visit Pellegrin Hospital in Bordeaux for a blood draw to measure hormone levels and a pelvic ultrasound to count developing egg follicles—both quick procedures. About two months later, you'll receive your results through a telehealth consultation. If any results are unusual, you'll be offered an appointment with a gynecologist to discuss next steps. The entire process is designed to be straightforward and supportive.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France